4.7 Review

Histone deacetylase 8 (HDAC8) and its inhibitors with selectivity to other isoforms: An overview

期刊

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
卷 164, 期 -, 页码 214-240

出版社

ELSEVIER FRANCE-EDITIONS SCIENTIFIQUES MEDICALES ELSEVIER
DOI: 10.1016/j.ejmech.2018.12.039

关键词

Histone deacetylase; HDAC8; Cancer; HDAC8 inhibitor; Structure-activity relationship (SAR); Quantitative structure-activity relationship (QSAR)

资金

  1. All India Council for Technical Education (AICTE) New Delhi
  2. University Grants Commission (UGC), New Delhi, India
  3. Jadavpur University, Kolkata under State Government Fellowship Scheme of Jadavpur University, Kolkata, India
  4. UPE Phase II Program of UGC, New Delhi

向作者/读者索取更多资源

The histone deacetylases (HDACs) enzymes provided crucial role in transcriptional regulation of cells through deacetylation of nuclear histone proteins. Discoveries related to the HDAC8 enzyme activity signified the importance of HDAC8 isoform in cell proliferation, tumorigenesis, cancer, neuronal disorders, parasitic/viral infections and other epigenetic regulations. The pan-HDAC inhibitors can confront these conditions but have chances to affect epigenetic functions of other HDAC isoforms. Designing of selective HDAC8 inhibitors is a key feature to combat the pathophysiological and diseased conditions involving the HDAC8 activity. This review is concerned about the structural and positional aspects of HDAC8 in the HDAC family. It also covers the contributions of HDAC8 in the pathophysiological conditions, a preliminary discussion about the recent scenario of HDAC8 inhibitors. This review might help to deliver the structural, functional and computational information in order to identify and design potent and selective HDAC8 inhibitors for target specific treatment of diseases involving HDAC8 enzymatic activity. (C) 2018 Elsevier Masson SAS. All rights reserved.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据